Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Comment by NovaAU10000on Aug 27, 2018 1:10pm
87 Views
Post# 28523394

RE:RE:RE:RE:RE:RE:IMEXF closed in the 0.06's today. IME at 0.09. DPD2 0.06

RE:RE:RE:RE:RE:RE:IMEXF closed in the 0.06's today. IME at 0.09. DPD2 0.06Yep, my mistake. Can't erase post here which you should be able to do. The info on IMEXF is correct per their own new release. Go read it. 

 The verified unit phase will not be complete by Optel until Mar 2019 at the earliest.  The clinical trials start in June 2019 going to at least Mar 2020 and if positive  FDA application can begin when the trails are finished Mar 2020(maybe) taking aonther 12 mo to  say Mar 2021. Production won't begin until 2021 after several more rounds of share offerings. This is from their own news release.

Bullboard Posts